Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000233807

Medchemexpress LLC Racemic MEM 1003 | 165187-25-7 | 99.6% | 10 MG
SDP

Catalog No. 5000233807
Encompass_Preferred

(Rac)-MEM 1003 is the racemate of MEM 1003, a dihydropyridine L-type calcium channel antagonist (CAS 165187-25-7) used in neuroscience research. The compound has formula C22H25ClN2O5 and molecular weight 432.9 g·mol⁻¹, and is supplied at high purity for research applications.

  • Racemic form of MEM 1003, a dihydropyridine calcium channel antagonist.
  • Potent L-type Ca2+ channel antagonist; useful in neuronal signaling studies.
  • High purity suitable for research use.
  • Available in small-scale quantities (e.g., 5 mg-100 mg) with larger sizes by request.
  • Certificate of analysis, datasheet, and safety data sheet available.

Catalog No. 50-002-33807 Supplier Medchemexpress LLC Supplier No. HY12160410MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

(Rac)-MEM 1003 is the racemate of MEM 1003, a dihydropyridine L-type calcium channel antagonist (CAS 165187-25-7) used in neuroscience research. The compound has formula C22H25ClN2O5 and molecular weight 432.9 g·mol⁻¹, and is supplied at high purity for research applications.

  • Racemic form of MEM 1003, a dihydropyridine calcium channel antagonist.
  • Potent L-type Ca2+ channel antagonist; useful in neuronal signaling studies.
  • High purity suitable for research use.
  • Available in small-scale quantities (e.g., 5 mg-100 mg) with larger sizes by request.
  • Certificate of analysis, datasheet, and safety data sheet available.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.